Increased expression of TERT mRNA expresssion in bone marrow-derived mesenchymal stem cells (BM-MSCs) in patients with chronic obstructive pulmonary disease (COPD): Preliminary results

K. Karagiannis, K. Antoniou, C. Kalpadaki, E. Vassalou, K. Samara, N. Siafakas, N. Tzanakis (Heraklion, Greece)

Source: Annual Congress 2010 - Novel mechanisms in COPD
Session: Novel mechanisms in COPD
Session type: Thematic Poster Session
Number: 4333
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Karagiannis, K. Antoniou, C. Kalpadaki, E. Vassalou, K. Samara, N. Siafakas, N. Tzanakis (Heraklion, Greece). Increased expression of TERT mRNA expresssion in bone marrow-derived mesenchymal stem cells (BM-MSCs) in patients with chronic obstructive pulmonary disease (COPD): Preliminary results. Eur Respir J 2010; 36: Suppl. 54, 4333

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
LSC 2010 Abstract: Does cigarette smoking influence bone marrow microenvironment? Down-regulation of CXCR4 expression in bone marrow-derived mesenchymal stem cells (BM-MSCs) in patients with chronic obstructive pulmonary disease (COPD): preliminary results
Source: Annual Congress 2010 - Novel mechanisms in COPD
Year: 2010

Increased TERT mRNA expression of bone marrow mesenchymal stem cells (BM-MSCs) in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010

Increased CXCR4 expression and short telomeres in bone marrow mesenchymal stem cells of patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis
Year: 2009


Expression of the biological axis VEGF-CXCL12/CXCR4 in bone marrow mesenchymal stem cells (BM MSCs) in patients with idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis
Year: 2008


Oral presentation: Increased CXCR4 expression and short telomeres in bone marrow mesenchymal stem cells of patients with idiopathic pulmonary fibrosis
Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis
Year: 2009



Functional characterisation of bone marrow-derived mesenchymal stromal cells from COPD patients
Source: ERJ Open Res 2016: 00045-2015
Year: 2016



Circulating haemopoietic and endothelial progenitor cells are decreased in COPD
Source: Eur Respir J 2006; 27: 529-541
Year: 2006



Results immunophenotyping cultured autologous mesenchymal stromal cell of patients with COPD and IPF in Belarus
Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases
Year: 2015

Upregulation of myeloid derived suppressor cells (MDSCs) in chronic obstructive pulmonary disease and its relationship with disease severity
Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms
Year: 2012

Bone marrow progenitor cells in patients with COPD
Source: Annual Congress 2010 - Novel insights into the pathophysiology of asthma and COPD
Year: 2010

Targeting of c-kit+ haematopoietic progenitor cells prevents hypoxic pulmonary hypertension
Source: Eur Respir J 2011; 37: 1392-1399
Year: 2011



Characterizing lung resident mesenchymal stem cells in idiopathic pulmonary fibrosis
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020

Circulating endothelial progenitor cells in patients with idiopathic pulmonary fibrosis (preliminary results)
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008


Functional comparison of bone-marrow derived mesenchymal stromal cells obtained from COPD patients and non-COPD controls
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015


Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury
Source: Eur Respir J 2009; 34: 740
Year: 2009



Human pulmonary arterial hypertension bone marrow-derived CD133+ myeloid progenitors induce vascular remodeling in immunodeficient mice
Source: Annual Congress 2011 - Pathobiology of experimental pulmonary hypertension
Year: 2011

Impaired migration of bone marrow mesenchymal stem cells in COPD
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013


Endothelial progenitor cells (EPC) in patients with chronic bronchitis or COPD
Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis
Year: 2009

Alterations of bone marrow derived endothelial progenitor cells following acute pulmonary embolism in mice
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease
Year: 2010


Implication of bone marrow-derived c-kit positive cells in idiopathic pulmonary arterial hypertension
Source: Annual Congress 2009 - Pathobiology of pulmonary hypertension
Year: 2009